Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.40
+23.0%
$0.38
$0.25
$0.48
$39.05M1.08913,992 shs214,616 shs
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
$0.03
$0.03
$0.01
$0.04
$11.28M-1.184,445 shsN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.20
+0.2%
$0.25
$0.17
$0.71
$37.58M0.8114,648 shs35,791 shs
AngioSoma, Inc. stock logo
SOAN
AngioSoma
$0.00
$0.00
$0.09
$32.57M-0.466.74 million shsN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-3.14%-1.96%+10.77%+31.48%+17.84%
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
0.00%0.00%0.00%0.00%+180.00%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
+0.20%+3.83%-13.81%-42.84%-66.86%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00%0.00%0.00%0.00%-60.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.40
+23.0%
$0.38
$0.25
$0.48
$39.05M1.08913,992 shs214,616 shs
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
$0.03
$0.03
$0.01
$0.04
$11.28M-1.184,445 shsN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.20
+0.2%
$0.25
$0.17
$0.71
$37.58M0.8114,648 shs35,791 shs
AngioSoma, Inc. stock logo
SOAN
AngioSoma
$0.00
$0.00
$0.09
$32.57M-0.466.74 million shsN/A
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-3.14%-1.96%+10.77%+31.48%+17.84%
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
0.00%0.00%0.00%0.00%+180.00%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
+0.20%+3.83%-13.81%-42.84%-66.86%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00%0.00%0.00%0.00%-60.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.00
Buy$3.88866.33% Upside
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
0.00
N/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00
N/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$1.33M27.44N/AN/A$0.08 per share5.01
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
$10K1,128.43N/AN/A$0.02 per share1.40
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$9.14M4.11N/AN/A($0.01) per share-20.04
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-$13M-$0.07N/AN/AN/A-714.16%-122.44%-88.40%N/A
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
-$9.01MN/A0.00N/AN/A-117.92%-102.44%N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-$21.12M-$0.03N/AN/A-115.14%N/A-60.81%N/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
-$540KN/A0.00N/AN/AN/AN/A-1,245.34%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/A
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
N/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/AN/AN/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.02
1.15
0.98
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
N/A
7.99
7.99
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/A
0.60
0.50
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
0.29
0.29

Institutional Ownership

CompanyInstitutional Ownership
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.87%
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.03%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.02%

Insider Ownership

CompanyInsider Ownership
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
23.66%
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
N/A
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
47.68%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
6190.81 million54.60 millionN/A
Abliva AB (publ) stock logo
NEVPF
Abliva AB (publ)
8403.01 millionN/ANot Optionable
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
90187.53 million96.34 millionNo Data
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A476.83 millionN/ANot Optionable

Recent News About These Companies

C-SPAN TV Schedule
C-SPAN Radio Schedule
C-SPAN 2 TV Schedule
Q&A with Riley Gaines
Senate Session
Martin Soan
Death Clock / Life Span Clock
Wisconsin for Kennedy
Sinking of Titanic
Senator Laphonza Butler on Book Bans
Attention Span Test
Jane Marie
The Showman
Super Tuesday Primary Results
South Carolina Republican Primary Coverage
Gateway to Statesmanship
About Books with Daniel Paisner
Lectures in History Videos

New MarketBeat Followers Over Time

Media Sentiment Over Time

IGC Pharma stock logo

IGC Pharma NYSEMKT:IGC

$0.40 +0.07 (+22.97%)
Closing price 09/19/2025 03:58 PM Eastern
Extended Trading
$0.40 +0.00 (+0.75%)
As of 09/19/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Abliva AB (publ) stock logo

Abliva AB (publ) OTCMKTS:NEVPF

$0.03 0.00 (0.00%)
As of 09/19/2025

Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYRGF

$0.20 +0.00 (+0.20%)
As of 09/19/2025 03:50 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.

AngioSoma stock logo

AngioSoma OTCMKTS:SOAN

AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.